Cargando…

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial

INTRODUCTION: Recent findings from onchocerciasis-endemic foci uphold that increasing ivermectin coverage reduces the epilepsy incidence, and anecdotal evidence suggests seizure frequency reduction in persons with onchocerciasis-associated epilepsy, when treated with ivermectin. We conducted a rando...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandro, Michel, Siewe Fodjo, Joseph Nelson, Mukendi, Deby, Dusabimana, Alfred, Menon, Sonia, Haesendonckx, Steven, Lokonda, Richard, Nakato, Swabra, Nyisi, Francoise, Abhafule, Germain, Wonya’Rossi, Deogratias, Jakwong, Jean Marie, Suykerbuyk, Patrick, Meganck, Jacques, Hotterbeekx, An, Colebunders, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977765/ https://www.ncbi.nlm.nih.gov/pubmed/31923177 http://dx.doi.org/10.1371/journal.pntd.0007966

Ejemplares similares

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
por: Mandro, Michel, et al.
Publicado: (2020)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
por: Lenaerts, Evy, et al.
Publicado: (2018)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
por: Dolo, Housseini, et al.
Publicado: (2018)

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial
por: Colebunders, Robert, et al.
Publicado: (2017)

Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
por: Mukendi, Deby, et al.
Publicado: (2019)

Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo
por: Hotterbeekx, An, et al.
Publicado: (2020)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania
por: Bhwana, Dan, et al.
Publicado: (2022)

Community perceptions and attitudes regarding epilepsy and disease cost after implementation of a community-based epilepsy treatment program in onchocerciasis-endemic communities in the Democratic Republic of Congo
por: Dusabimana, Alfred, et al.
Publicado: (2021)

Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Onchocerciasis‐associated epilepsy: From recent epidemiological and clinical findings to policy implications
por: Colebunders, Robert, et al.
Publicado: (2017)

Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa
por: Siewe Fodjo, J N, et al.
Publicado: (2019)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus
por: Dusabimana, Alfred, et al.
Publicado: (2020)

The onchocerciasis hypothesis of nodding syndrome
por: Colebunders, Robert, et al.
Publicado: (2023)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study
por: Hotterbeekx, An, et al.
Publicado: (2021)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2021)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
por: Boullé, Charlotte, et al.
Publicado: (2019)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes
por: Colebunders, Robert, et al.
Publicado: (2019)

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
por: Gumisiriza, Nolbert, et al.
Publicado: (2020)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
por: Colebunders, Robert, et al.
Publicado: (2022)

Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study
por: Mandro, Michel, et al.
Publicado: (2018)

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
por: Kaiser, Christoph, et al.
Publicado: (2019)

Report of the first international workshop on onchocerciasis-associated epilepsy
por: Colebunders, Robert, et al.
Publicado: (2018)

Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study
por: Bhwana, Dan, et al.
Publicado: (2023)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2020)

Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2018)

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
por: Mmbando, Bruno P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3l5249fdja3dsv0vg9h8naeijq